MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

aTyr Pharma Company Profile (NASDAQ:LIFE)

Consensus Ratings for aTyr Pharma (NASDAQ:LIFE) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $40.00 (1,146.11% upside)

Analysts' Ratings History for aTyr Pharma (NASDAQ:LIFE)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016BMO Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2015Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha